2seventy bio, Inc.
DelistedCIK 1860782fmd_1P78X4VBJ8S265P5A0AYG84M26Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Mar 31, 2025, 20 periods
Latest annual · FY2024
Millions- Total revenues
- 38
- Gross profit
- 38
- Operating income
- (115)
- Net income
- (57)
- Free cash flow
- (86)
Latest quarter · Q1 FY2025
Millions- Total revenues
- 23
- Gross profit
- 3
- Operating income
- (3)
- Net income
- 0
- Free cash flow
- (11)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- -11.4%
- Revenue, 5 yearsFY2019 to FY2024
- -3.1%
- Net income, 5 yearsFY2019 to FY2024
- n/m
2seventy bio, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $37.9 million | $100.4 million | -62.3% | 10-K 2025-03-25 · proof |
| Gross profit | $37.9 million | $98.3 million | -61.5% | 10-K 2025-03-25 · proof |
| Operating income | -$115.4 million | -$237.6 million | 10-K 2025-03-25 · proof | |
| Net income | -$57.2 million | -$217.6 million | 10-K 2025-03-25 · proof | |
| Cash from operating activities | -$85 million | -$166.9 million | 10-K 2025-03-25 · proof | |
| Free cash flow | -$85.7 million | -$180.7 million | 10-K 2025-03-25 · proof | |
| Total assets | $479.5 million | $565.4 million | -15.2% | 10-K 2025-03-25 · proof |
| Total liabilities | $268.7 million | $310.1 million | -13.4% | 10-K 2025-03-25 · proof |
| Cash and cash equivalents | $71.2 million | $75 million | -5% | 10-K 2025-03-25 · proof |
- What was 2seventy bio, Inc.'s revenue in fiscal 2024?
- 2seventy bio, Inc. reported revenue of $37.9 million for fiscal 2024 (the year ended Dec 31, 2024), against $100.4 million the year before (-62.3%). Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What was 2seventy bio, Inc.'s gross profit in fiscal 2024?
- 2seventy bio, Inc. reported gross profit of $37.9 million for fiscal 2024 (the year ended Dec 31, 2024), against $98.3 million the year before (-61.5%). Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What was 2seventy bio, Inc.'s operating income in fiscal 2024?
- 2seventy bio, Inc. reported operating income of -$115.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$237.6 million the year before. Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What was 2seventy bio, Inc.'s net income in fiscal 2024?
- 2seventy bio, Inc. reported net income of -$57.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$217.6 million the year before. Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What was 2seventy bio, Inc.'s cash from operating activities in fiscal 2024?
- 2seventy bio, Inc. reported cash from operating activities of -$85 million for fiscal 2024 (the year ended Dec 31, 2024), against -$166.9 million the year before. Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What was 2seventy bio, Inc.'s free cash flow in fiscal 2024?
- 2seventy bio, Inc. reported free cash flow of -$85.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$180.7 million the year before. Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What are 2seventy bio, Inc.'s total assets?
- As of Dec 31, 2024, 2seventy bio, Inc. reported total assets of $479.5 million, against $565.4 million a year earlier (-15.2%). Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What are 2seventy bio, Inc.'s total liabilities?
- As of Dec 31, 2024, 2seventy bio, Inc. reported total liabilities of $268.7 million, against $310.1 million a year earlier (-13.4%). Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
- What are 2seventy bio, Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, 2seventy bio, Inc. reported cash and cash equivalents of $71.2 million, against $75 million a year earlier (-5%). Source: the 10-K filed with the SEC on Mar 25, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1860782&period_type=annual&limit=5"Information only, not investment advice.